Depression News and Research

Latest Depression News and Research

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.

4 Oct 2010

New SymPath kit measures DBH activity of Sympathetic Nervous System

Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.

4 Oct 2010

Telemedicine can help address mental health needs of elderly homebound individuals

Studies have shown a high rate of depression among elderly homebound individuals, and few patients receive adequate treatment, if any. To address this issue, researchers at Rhode Island Hospital and other organizations have developed a telemedicine-based depression care protocol in home health care.

4 Oct 2010

Scientists find several common findings on diabetes management

Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.

3 Oct 2010

Noven acquires global rights to Daytrana from Shire affiliates

Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.

1 Oct 2010

Cortex regains global rights to AMPAKINE compounds for treatment of schizophrenia and depression

Cortex Pharmaceuticals, Inc. announced that it has regained worldwide rights to develop and commercialize its AMPAKINE® compounds for the treatment of schizophrenia and depression.

1 Oct 2010

Intra-Cellular Therapies demonstrates ability of ITI-002 to improve motor and non-motor behaviors in PD

Intra-Cellular Therapies, Inc. today announced results from studies demonstrating the anti-Parkinson and other beneficial effects of ITI-002 (IC200214), the Company's novel and selective phosphodiesterase type I (PDE1) inhibitor.

1 Oct 2010

Study examines link between insufficient sleep and blood pressure among pregnant women

A study in the Oct. 1 issue of the journal Sleep found that getting too little or too much sleep in early pregnancy is associated with elevated blood pressure in the third trimester. The study suggests that improving prenatal sleep hygiene may provide important health benefits.

1 Oct 2010

Family and friends may pose the greatest threat to caregivers' health and well-being

The biggest cause of stress for people who care for loved ones after a stroke may not be worrying about the affected family member.

1 Oct 2010

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Repligen Corporation reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

30 Sep 2010

Legal storm brews in area of mental health protection at work

Financial rewards for damages caused by mental injury at work have increased over the past five years by as much as 700%, according to a report released today by the Mental Health Commission of Canada (MHCC). The report warns that a perfect legal storm is brewing in the area of mental health protection at work, and points to emerging responsibilities for employers to provide a psychologically safe workplace. This is timely, since October is Canada's Healthy Workplace Month and next week is Mental Illness Awareness Week.

30 Sep 2010

Men may connect strongly to publicity campaigns about depression and suicide

A recent study revealed that men might connect strongly to publicity campaigns about depression and suicide, particularly when they have options for anonymous help. In Regensburg, Germany, a two-year intervention campaign resulted in a marked drop in male suicides.

30 Sep 2010

Midlife crisis is hitting Britons earlier: Survey

The latest British research shows that the tmidlife crisis that was once thought to hit people on their fifties is now affecting people in their mid-thirties. The changes in the work culture may be the main reason say researchers.

30 Sep 2010

New computer program to help young adults manage mental illness

While many young adults will share the details of their daily lives with dozens - sometimes hundreds - of friends on Facebook, communicating with their health care providers about mental illness is another story.

29 Sep 2010

Canadians living with depression significantly underestimate others' perceptions about illness

A new national survey reveals a vast gap between how Canadians living with depression view their condition, compared to how it is viewed in reality by the general population, possibly preventing them from seeking the best treatment and care. Most Canadians with depression feel their illness is not perceived by the public as a medical condition or a serious illness (81 per cent) when in fact less than five per cent of the general population actually has that view. In fact, the majority of Canadians (72 per cent) recognize depression as both serious and treatable.

29 Sep 2010

Teens who experience manic phase of bipolar disorder more likely to engage in high risk sexual behaviors

Although research has shown that teens with mental health disorders are more likely to engage in high risk sexual behaviors, like unprotected sex, a new study from the Bradley Hasbro Children's Research Center suggests there is an additional risk associated with certain psychiatric diagnoses.

29 Sep 2010

Study reveals hunger costs Minnesotans $1.62 billion per annum

A University of Minnesota Food Industry Center study funded by Target and released today reveals that hunger is costing Minnesotans upwards of $1.62 billion annually in direct and indirect health and education costs. The Cost/Benefit Study also suggests that interventions aimed at preventing hunger are sound moral, social and financial investments.

28 Sep 2010

Researchers develop microelectronic circuitry to guide axon growth in damaged brain

Researchers in the Midwest are developing microelectronic circuitry to guide the growth of axons in a brain damaged by an exploding bomb, car crash or stroke. The goal is to rewire the brain connectivity and bypass the region damaged by trauma, in order to restore normal behavior and movement.

28 Sep 2010

Children with food allergies experience bullying: Study

In the first ever study to assess the social impact of food allergies in children, Mount Sinai researchers have found that approximately 35 percent of children with food allergies, who are over the age of five, were reported to have experienced bullying, teasing, or harassment as a result of their allergies.

28 Sep 2010

Women's mental health issues to be discussed at 2010 Marc- Society International Conference

Nearly 500 researchers, clinicians and mental health advocates are expected to attend the 2010 Marc- Society International Conference, Perinatal Mental Health Research: Harvesting the Potential, Oct. 26 to 30, at the Sheraton Station Square Hotel in Pittsburgh. The event, which focuses on women's mental health issues related to childbearing, will feature keynote speaker former First Lady Rosalynn Carter, who has been an active advocate for mental health reform.

28 Sep 2010

Depression News and Research

Latest Depression News and Research

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

New SymPath kit measures DBH activity of Sympathetic Nervous System

Telemedicine can help address mental health needs of elderly homebound individuals

Scientists find several common findings on diabetes management

Noven acquires global rights to Daytrana from Shire affiliates

Cortex regains global rights to AMPAKINE compounds for treatment of schizophrenia and depression

Intra-Cellular Therapies demonstrates ability of ITI-002 to improve motor and non-motor behaviors in PD

Study examines link between insufficient sleep and blood pressure among pregnant women

Family and friends may pose the greatest threat to caregivers' health and well-being

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Legal storm brews in area of mental health protection at work

Men may connect strongly to publicity campaigns about depression and suicide

Midlife crisis is hitting Britons earlier: Survey

New computer program to help young adults manage mental illness

Canadians living with depression significantly underestimate others' perceptions about illness

Teens who experience manic phase of bipolar disorder more likely to engage in high risk sexual behaviors

Study reveals hunger costs Minnesotans $1.62 billion per annum

Researchers develop microelectronic circuitry to guide axon growth in damaged brain

Children with food allergies experience bullying: Study

Women's mental health issues to be discussed at 2010 Marc- Society International Conference

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in